×
Fulgent Genetics EBIT 2015-2024 | FLGT
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Fulgent Genetics ebit from 2015 to 2024. Ebit can be defined as earnings before interest and taxes.
View More
Fulgent Genetics EBIT 2015-2024 | FLGT
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Fulgent Genetics ebit from 2015 to 2024. Ebit can be defined as earnings before interest and taxes.
Related Stocks
Company Name
Market
Cap
Tempus AI (TEM)
$9.2B
Inspire Medical Systems (INSP)
$5.7B
Hims & Hers Health (HIMS)
$5.5B
Enovis (ENOV)
$2.6B
Privia Health (PRVA)
$2.6B
IRhythm Technologies (IRTC)
$2.3B
Azenta (AZTA)
$2.2B
Omnicell (OMCL)
$2.1B
10x Genomics (TXG)
$1.7B
Clover Health Investments (CLOV)
$1.7B
Schrodinger (SDGR)
$1.5B
Phreesia (PHR)
$1.1B
Butterfly Network (BFLY)
$690M
Standard BioTools (LAB)
$596M
Talkspace (TALK)
$583M
Definitive Healthcare (DH)
$505M
Health Catalyst (HCAT)
$495M
Pulmonx (LUNG)
$268M
TruBridge (TBRG)
$247M
SOPHiA GENETICS SA (SOPH)
$209M
American Well (AMWL)
$124M
EUDA Health Holdings (EUDA)
$112M
P3 Health Partners (PIII)
$76M
HeartBeam (BEAT)
$74M
111 (YI)
$52M
CareCloud (CCLD)
$46M
Outset Medical (OM)
$44M
SHL Telemedicine (SHLT)
$42M
Zepp Health (ZEPP)
$37M
Movano (MOVE)
$23M